CR20200359A - Materiales de autoensamblaje coordinados con superficie de contacto viva compleja (clicsam) - Google Patents

Materiales de autoensamblaje coordinados con superficie de contacto viva compleja (clicsam)

Info

Publication number
CR20200359A
CR20200359A CR20200359A CR20200359A CR20200359A CR 20200359 A CR20200359 A CR 20200359A CR 20200359 A CR20200359 A CR 20200359A CR 20200359 A CR20200359 A CR 20200359A CR 20200359 A CR20200359 A CR 20200359A
Authority
CR
Costa Rica
Prior art keywords
clicsam
assembling materials
complex living
coordinated self
interface
Prior art date
Application number
CR20200359A
Other languages
English (en)
Inventor
Nicholas Baetz
Denver Lough
Nikolai Sopko
Pratima Labroo
Original Assignee
Polarityte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Polarityte Inc filed Critical Polarityte Inc
Publication of CR20200359A publication Critical patent/CR20200359A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
    • C12N5/0659—Satellite cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Transplantation (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

<p>En este documento se divulga una composición que comprende un agregado celular de contacto con tejido de mamífero heterogéneo estimulado que puede producir tejido polarizado funcional cuando se administra a un sujeto que lo necesita.</p>
CR20200359A 2018-01-26 2019-01-28 Materiales de autoensamblaje coordinados con superficie de contacto viva compleja (clicsam) CR20200359A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862622489P 2018-01-26 2018-01-26
PCT/US2019/015486 WO2019148143A1 (en) 2018-01-26 2019-01-28 Complex living interface-coordinated self-assembling materials (clicsam)

Publications (1)

Publication Number Publication Date
CR20200359A true CR20200359A (es) 2020-11-05

Family

ID=67393072

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20200359A CR20200359A (es) 2018-01-26 2019-01-28 Materiales de autoensamblaje coordinados con superficie de contacto viva compleja (clicsam)

Country Status (10)

Country Link
US (1) US20190231932A1 (es)
EP (1) EP3743080A4 (es)
JP (1) JP2021511937A (es)
CN (2) CN111683695A (es)
AU (1) AU2019212976A1 (es)
BR (1) BR112020015149A2 (es)
CA (1) CA3088130A1 (es)
CR (1) CR20200359A (es)
IL (1) IL275844A (es)
WO (1) WO2019148143A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD847859S1 (en) * 2017-03-22 2019-05-07 Biosense Webster (Israel) Ltd. Display screen or portion thereof with icon

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2479510C (en) * 2002-03-15 2019-10-29 University Of North Carolina At Chapel Hill Primitive and proximal hepatic stem cells
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
US7498041B2 (en) * 2005-10-12 2009-03-03 Lifenet Health Composition for repair of defects in osseous tissues
US9132208B2 (en) * 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
CN101355929A (zh) * 2005-12-23 2009-01-28 哈多技术有限公司 治疗和预防变应性疾病的方式和方法
EP2245141B1 (en) * 2008-01-18 2018-03-14 Regents of the University of Minnesota Stem cell aggregates and methods for making and using
SI2310491T1 (en) * 2008-06-20 2018-07-31 Universiteit Maastricht Only composite tissue modules
US20100098739A1 (en) * 2008-10-20 2010-04-22 University Of Virginia Patent Foundation Compositions and methods for modular soft tissue repair
WO2011031875A2 (en) * 2009-09-11 2011-03-17 Fate Therapeutics, Inc. Cell-based compositions and uses thereof
US10926001B2 (en) * 2014-12-02 2021-02-23 Polarityte, Inc. Methods related to minimally polarized functional units
WO2016172004A1 (en) * 2015-04-18 2016-10-27 The Johns Hopkins University Bone healing, angiogenesis-promoting and vasculogenesis-producing system
JP2021511936A (ja) * 2018-01-26 2021-05-13 ポラリティー・ティー・イー・インコーポレーテッド 混成界面接続生体材料促進剤基質

Also Published As

Publication number Publication date
IL275844A (en) 2020-08-31
CN111683695A (zh) 2020-09-18
EP3743080A1 (en) 2020-12-02
BR112020015149A2 (pt) 2021-01-05
AU2019212976A1 (en) 2020-07-23
US20190231932A1 (en) 2019-08-01
CN114712563A (zh) 2022-07-08
CA3088130A1 (en) 2019-08-01
WO2019148143A1 (en) 2019-08-01
EP3743080A4 (en) 2021-10-27
JP2021511937A (ja) 2021-05-13

Similar Documents

Publication Publication Date Title
CY1118407T1 (el) Αντισωματα εξουδετερωσης υποδοχεα προλακτινης και θεραπευτικη χρηση αυτων
MX2018004146A (es) Células modificadas genéticamente que comprenden un gen mano modificado de la región constante alfa del receptor de células t.
TR201821186T4 (tr) Uzun süre etkili büyüme hormonu ve bunun üretim metotları.
NZ703153A (en) Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof
PH12014502414A1 (en) Novel compounds
MX2013012798A (es) Compuestos heterociclicos fusionados como moduladores del canal de sodio.
RU2012134318A (ru) Стабилизация пленки оксида цинка в композициях для ухода за полостью рта
MX2013002488A (es) Métodos y composiciones para suministrar un antagonista del receptor interleucina-1.
MX363457B (es) Compuestos de sulfonamida heterociclica sustituida utiles como moduladores del canal del receptor de potencial transitorio a1 (trpa1).
RU2012130364A (ru) Антагонисты wnt и способы лечения и тестирования
CL2015002202A1 (es) Benzamidas sustituidas con actividad hacia receptores ep4.
CR20200359A (es) Materiales de autoensamblaje coordinados con superficie de contacto viva compleja (clicsam)
NZ720651A (en) Fused heterocyclic compounds as ion channel modulators
AU2019268087A1 (en) Compound of glycosaminoglycan, preparation method and use thereof
MX2014002112A (es) Compuestos de pirimido-piridazinona y uso de los mismos.
BR102014006335B8 (pt) Método para produzir uma população isolada de células-tronco de polpa dentária imaturas (idpscs) e uso
MX2019013071A (es) Metodo de tratamiento inmunoterapeutico de un tumor.
EA201690612A1 (ru) Составы зубной пасты для доставки аллергенов в слизистую оболочку полости рта
MX2015013148A (es) Nuevos compuestos de bencensulfonamida, metodo para sintetizar los mismos, y uso de los mismos en medicina asi como tambien en cosmeticos.
MX2020005235A (es) Celula humana transformada y uso de la misma.
EA201290534A1 (ru) Бициклические тиазолы в качестве аллостерических модуляторов mglur5 рецепторов
BR112013003989A2 (pt) características e propriedades citolíticas de células expressando th1
SG10201710666UA (en) Pharmaceutical composition to be used for treatment of infertility and method for producing same
EP4389218A3 (en) Composition for treating joint disease and kit containing same
MY197247A (en) Recombinant glycoproteins and uses thereof